Trending Aesthetic Treatments: What Patients Are Asking For

The injectable market has expanded significantly with recent FDA clearances. Skinvive by Juvéderm (Allergan Aesthetics) received approval for neck wrinkles and horizontal neck lines—a new indication addressing "tech neck" and age-related neck skin quality. Restylane Contour (Galderma) gained clearance for temple hollowing, expanding the filler portfolio beyond traditional midface and lip work. RHA Dynamic Volume (Revance) was approved for midface augmentation and age-related volume loss, targeting dynamic facial movement. Additionally, Boey (trenibotulinumtoxinE, Allergan Aesthetics) received Health Canada approval as a rapid-onset, short-duration neuromodulator—a differentiated option in the botulinum toxin category.

What to check: Visit the FDA's website for the exact indication, patient population, and injection technique for each product. Review Allergan, Galderma, and Revance product pages for training requirements, reimbursement codes, and patient education materials. Verify whether your state's scope of practice permits your staff to inject these products. Consider stocking decisions based on patient demographics (neck concerns are rising; temple hollowing appeals to specific age groups).

Medical aesthetics industry leaders have confirmed that GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) cause facial fat loss—colloquially called "semaglutide face" or "ghost fat." Patients on these medications experience rapid weight loss and concurrent loss of facial volume, leading to a hollowed, aged appearance. This is driving new patient inquiries for volume restoration treatments: fillers, fat transfer, and combination approaches.

What to check: Educate your team on the mechanism (GLP-1 drugs accelerate fat loss in the face, not just the body). Ask intake questions about weight-loss medication use. Position volume-restoration treatments (fillers, microfat grafting if offered) as complementary to weight loss. Monitor Novo Nordisk, Eli Lilly, and Amgen announcements regarding GLP-1 product labeling and side-effect communications. This trend is likely to persist and grow, creating a sustained demand driver for your practice.

Neck appearance—including horizontal lines, skin laxity, and "tech neck"—is becoming a primary patient concern, evidenced by Skinvive's FDA approval for this indication. Jawline definition and contouring are also rising in demand. These areas require precise injection technique, anatomical knowledge, and often combination approaches (neuromodulator + filler, or filler + microneedling/radiofrequency).

What to check: Ensure your injectors have advanced training in neck anatomy and injection depth. Neck skin is thinner and more mobile than the face; improper technique risks visible bumps, asymmetry, or dysphagia. Invest in continuing education through your product suppliers (Allergan, Galderma, Revance) or aesthetic societies (American Academy of Dermatology, American Society of Plastic Surgeons). Consider bundling neck treatments with facial work to increase average transaction value and patient satisfaction.

Patients increasingly seek layered, customized approaches rather than single-modality treatments. Combining neuromodulators, fillers, and energy-based devices (microneedling, radiofrequency) in one visit—or across a series—allows for more natural results and addresses multiple concerns simultaneously. This trend supports higher-ticket packages and stronger patient loyalty.

What to check: Audit your current service menu. Are you offering combination packages (e.g., "Neck Refresh," "Jawline Definition," "GLP-1 Recovery")? Do your pricing and scheduling accommodate multi-step treatments? Train staff on cross-selling and patient education so clients understand the rationale for combinations. Review your liability insurance to ensure coverage for multi-modality treatments. Verify that your state's regulations permit your staff to perform these combinations (some states restrict certain device use to physicians).

Recent enforcement actions—including a high-profile case involving an unlicensed medspa operator and a former medspa owner convicted in a botched surgery case—underscore the importance of proper licensing, training, and informed consent. FDA approvals for new indications and products also mean updating your protocols, consent forms, and staff training.

What to check: Verify that all injectors hold current, valid licenses (RN, PA, NP, MD/DO, or state-specific aesthetician credentials, depending on your state and scope). Maintain detailed records of training for each new product or indication. Update consent forms to reflect new approvals and risks. Review your state's medical board and nursing board websites for scope-of-practice updates. Ensure your malpractice insurance covers all treatments you offer. Consider joining professional organizations (ASPS, AAD, ASLMS) for liability protection, continuing education, and regulatory updates.

With multiple new products and indications, prioritize based on patient demand in your market, staff expertise, and profitability. Not every new approval requires immediate adoption. Neck treatments (Skinvive) may resonate in an older demographic; temple hollowing (Restylane Contour) may appeal to a younger, contouring-focused clientele. Rapid-onset neuromodulators (Boey) may attract patients seeking faster results or shorter duration.

What to check: Survey your patient base and review your booking data to identify top concerns and underserved areas. Consult your product representatives about training timelines, minimum order quantities, and pricing. Calculate the ROI for each new treatment (cost of product, training, marketing, and expected patient volume). Prioritize one or two new offerings per quarter to avoid overwhelming your team. Track patient satisfaction and outcomes for each new treatment to refine your menu over time.

As treatments expand, so does the need for clear, evidence-based patient education. Patients may confuse new products (e.g., Boey vs. Botox), misunderstand indications (e.g., Skinvive is for skin quality, not deep lines), or have unrealistic expectations about results or timelines. Effective marketing and pre-visit education reduce complications and boost satisfaction.

What to check: Work with your product suppliers to access FDA-approved patient education materials. Create simple, visual guides explaining each treatment, expected results, timeline, and cost. Train your front desk and consultation staff to answer common questions accurately. Use your website and social media to educate (not just promote). Consider hosting patient webinars or lunch-and-learns on trending treatments. Ensure all marketing claims are truthful and supported by clinical data; avoid off-label claims or exaggerated results. Review your state's medical board advertising guidelines to stay compliant.